Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $137.92 USD
Change Today -1.61 / -1.15%
Volume 880.5K
As of 3:06 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

thermo fisher scientific inc (TMO) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - $141.25
52 Week Low
10/15/14 - $107.33
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

thermo fisher scientific inc (TMO) Details

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. It serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as the clinical laboratory. The company’s Specialty Diagnostics segment offers liquid, ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratory customers. Its Laboratory Products and Services segment offers sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, water analysis instruments, and other laboratory equipment, as well as laboratory consumables, research and safety market solutions, and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

51,000 Employees
Last Reported Date: 03/5/15
Founded in 1956

thermo fisher scientific inc (TMO) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.3M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $674.0K
Executive Vice President and President of Lif...
Total Annual Compensation: $723.1K
Executive Vice President and President of Lab...
Total Annual Compensation: $716.2K
Senior Vice President and President of Analyt...
Total Annual Compensation: $568.1K
Compensation as of Fiscal Year 2014.

thermo fisher scientific inc (TMO) Key Developments

Thermo Fisher Unveils Pricing for EUR 500 Million Note Offering

Thermo Fisher Scientific Inc. announced on pricing details for a euro-denominated debt offering intended to raise EUR 500 million (USD 545 million). The senior notes, which will mature in 2022, carry an annual interest of 2.150% and are priced at 99.788% of their face value. Thermo Fisher expects the issuance to close on or about July 21, 2015, pending standard conditions. The net proceeds will be used for general corporate purposes.

Thermo Fisher Scientific Introduces PrioCHECK Trichinella AAd to Test Swine Carcasses for Trichinella

Thermo Fisher Scientific Introduced PrioCHECK Trichinella AAD. Abattoirs and meat packers have a cleaner, safer way to test swine carcasses for potentially dangerous Trichinella at meat inspection – new PrioCHECK Trichinella AAD. The alternative artificial digestion (AAD) method has been validated and approved by the European Union and is listed in commission regulation (EC) 2075/2005. PrioCHECK Trichinella AAD is a reliable alternative to the currently used pepsin-based artificial digestion method, because the test uses a recombinantly produced enzyme from a standardized and secured production facility, ensuring good availability of the enzyme and consistent quality. In addition, it does not use pepsin powder or hydrochloric acid, increasing ease of handling and worker safety. The Community Reference Laboratory (CRL) for Trichinella in Rome has extensively validated the performance of the PrioCHECK Trichinella AAD Kit and has approved the product as an official method for use in the in vitro detection of Trichinella spp. in meat of domestic swine.

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2015

Thermo Fisher Scientific Inc. announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on October 15, 2015, to shareholders of record as of September 15, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMO:US $137.92 USD -1.61

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $50.22 USD -0.47
Biogen Inc $323.21 USD +4.43
Danaher Corp $91.01 USD -0.55
Safran SA €69.75 EUR +0.89
Syngenta AG SFr.408.40 CHF +10.40
View Industry Companies

Industry Analysis


Industry Average

Valuation TMO Industry Range
Price/Earnings 28.5x
Price/Sales 3.3x
Price/Book 2.7x
Price/Cash Flow 27.8x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at